Phase III Trial Comparing Granulocyte Colony-Stimulating Factor to Leridistim in the Prevention of Neutropenic Complications in Breast Cancer Patients Treated with Docetaxel/Doxorubicin/Cyclophosphamide: Results of the BCIRG 004 Trial

Autor: Nabholtz, Jean-Marc, Cantin, Jacques, Chang, Jose, Guevin, Raymond, Patel, Ravi, Tkaczuk, Katherine, Vodvarka, Pavel, Lindsay, Mary-Ann, Reese, David, Riva, Alessandro, Mackey, John
Zdroj: In Clinical Breast Cancer 2002 3(4):268-275
Databáze: ScienceDirect
Externí odkaz: